Better Care for ALS Patients: New Medicare Funding Without Copayments
This act establishes a new, dedicated payment system within Medicare to significantly increase funding for specialized medical services for individuals diagnosed with Amyotrophic Lateral Sclerosis (ALS). The most crucial change for citizens is that ALS patients covered by Medicare will incur zero out-of-pocket costs (no deductibles or copayments) for these essential, multidisciplinary clinic visits. This aims to improve the quality of life, reduce wait times, and encourage facilities to invest in innovation and clinical research.
Key points
Medicare introduces a new, supplemental payment (starting at $800 per visit) for facilities providing comprehensive services to ALS patients, ensuring better funding for specialized care.
ALS patients covered by Medicare will face no cost sharing (zero copayments or deductibles) for these specialized visits and services.
Covered services include support from specialized physicians, nurses, physical therapy, speech pathology, dietary support, and coordination of durable medical equipment.
The law mandates a report on challenges in administering ALS clinical trials to accelerate the development of new treatments.
Expired
Citizen Poll